BACKGROUND: We studied cardiopulmonary function during exercise in young subjects with long-standing insulin-dependent diabetes mellitus (IDDM) who have no clinical cardiopulmonary disease to determine the relationships of aerobic capacity, gas exchange, ventilatory power requirement, and cardiac output to chronic glycemic control. METHODS: Eighteen subjects with IDDM and 14 normal control subjects were studied. Nine diabetic subjects received twice daily insulin injections and had chronically elevated levels of glycosylated hemoglobin (hyperglycemic group); 9 other diabetic subjects received insulin via continuous infusion pumps and maintained chronic near-normal levels of glycosylated hemoglobin (normoglycemic group). At the end of at least 7 years of regular follow-up, aerobic capacity was determined by cycle ergometry. Lung volume, diffusing capacity, and cardiac output during exercise were measured by a rebreathing technique. Ventilatory power was measured by the esophageal balloon technique. RESULTS: Maximal work load and oxygen uptake were markedly impaired in chronically hyperglycemic diabetic patients associated with significant restrictions of lung volume, lung diffusing capacity, and stroke index during exercise. Membrane diffusing capacity was significantly reduced at a given cardiac index. The normoglycemic patients consistently showed less impairment than the hyperglycemic patients. CONCLUSION: Physiologically significant cardiopulmonary dysfunction develops in asymptomatic patients with long-standing IDDM. Chronic maintenance of near-normoglycemia is associated with improved cardiopulmonary function.
BACKGROUND: We studied cardiopulmonary function during exercise in young subjects with long-standing insulin-dependent diabetes mellitus (IDDM) who have no clinical cardiopulmonary disease to determine the relationships of aerobic capacity, gas exchange, ventilatory power requirement, and cardiac output to chronic glycemic control. METHODS: Eighteen subjects with IDDM and 14 normal control subjects were studied. Nine diabetic subjects received twice daily insulin injections and had chronically elevated levels of glycosylated hemoglobin (hyperglycemic group); 9 other diabetic subjects received insulin via continuous infusion pumps and maintained chronic near-normal levels of glycosylated hemoglobin (normoglycemic group). At the end of at least 7 years of regular follow-up, aerobic capacity was determined by cycle ergometry. Lung volume, diffusing capacity, and cardiac output during exercise were measured by a rebreathing technique. Ventilatory power was measured by the esophageal balloon technique. RESULTS: Maximal work load and oxygen uptake were markedly impaired in chronically hyperglycemic diabeticpatients associated with significant restrictions of lung volume, lung diffusing capacity, and stroke index during exercise. Membrane diffusing capacity was significantly reduced at a given cardiac index. The normoglycemic patients consistently showed less impairment than the hyperglycemicpatients. CONCLUSION: Physiologically significant cardiopulmonary dysfunction develops in asymptomatic patients with long-standing IDDM. Chronic maintenance of near-normoglycemia is associated with improved cardiopulmonary function.
Authors: Timothy J Roberts; Andrew T Burns; Richard J MacIsaac; Andrew I MacIsaac; David L Prior; André La Gerche Journal: J Appl Physiol (1985) Date: 2019-05-02
Authors: Dario Pitocco; Leonello Fuso; Emanuele G Conte; Francesco Zaccardi; Carola Condoluci; Giuseppe Scavone; Raffaele A Incalzi; Giovanni Ghirlanda Journal: Rev Diabet Stud Date: 2012-05-10
Authors: Astrid H Petersen; Gerd Köhler; Stefan Korsatko; Andrea Wutte; Manfred Wonisch; Agnes Mautner; Birgitte B Rønn; Per Clauson; Torben Laursen; Per Wollmer; Thomas R Pieber Journal: Br J Clin Pharmacol Date: 2007-08-31 Impact factor: 4.335
Authors: Oana L Klein; Larissa Aviles-Santa; Jianwen Cai; Harold R Collard; Alka M Kanaya; Robert C Kaplan; Gregory L Kinney; Eliana Mendes; Lewis Smith; Gregory Talavera; Donghong Wu; Martha Daviglus Journal: Diabetes Care Date: 2016-09-09 Impact factor: 19.112
Authors: William W Chance; Chanhaeng Rhee; Cuneyt Yilmaz; D Merrill Dane; M Lourdes Pruneda; Philip Raskin; Connie C W Hsia Journal: Diabetes Care Date: 2008-05-20 Impact factor: 19.112
Authors: Anne S Koponen; Juha E Peltonen; Marja K Päivinen; Jyrki M Aho; Harriet J Hägglund; Arja L Uusitalo; Harri J Lindholm; Heikki O Tikkanen Journal: Eur J Appl Physiol Date: 2012-11-06 Impact factor: 3.078
Authors: David J Foster; Priya Ravikumar; Dennis J Bellotto; Roger H Unger; Connie C W Hsia Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-01-08 Impact factor: 5.464